Analysis of polymorphisms in genes (AGT, MTHFR, GPIIIa, and GSTP1) associated with hypertension, thrombophilia and oxidative stress in Mestizo and Amerindian populations of México

Disease Markers

Volumn 28, Issue 5, 2010, Pages 323-331

  Juárez Velázquez, Rocio ^a,b   Canto, Patricia ^c   Canto Cetina, Thelma ^d   Rangel Villalobos, Hector ^e   Rosas Vargas, Haydee ^a   Rodríguez, Maricela ^f   Canizales Quinteros, Samuel ^g   Velázquez Wong, Ana Claudia ^a   Ordoez Razo, Rosa María ^a   Vilchis Dorantes, Guadalupe ^h   Coral Vázquez, Ramón Mauricio ^c,i  

^a HOSPITAL DE PEDIATRÍA   (Mexico)

^b INSTITUTO NACIONAL DE PEDIATRÍA   (Mexico)

^c CENTRO MÉDICO NACIONAL 20 DE NOVIEMBRE   (Mexico)

^d UNIVERSIDAD AUTÓNOMA DE YUCATÁN   (Mexico)

^e UNIVERSITY OF GUADALAJARA   (Mexico)

^f INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^g INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^h Dir Coord Gen Servicios P   (Mexico)

ⁱ INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

Author keywords

AGT; Gene polymorphisms; GPIIIa; GSTP1; Mexican populations; MTHFR

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ANGIOTENSINOGEN; GLUTATHIONE TRANSFERASE P1; GLYCOPROTEIN IIIA; BETA3 INTEGRIN; DNA; GSTP1 PROTEIN, HUMAN; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2);

ADULT; ALLELE; AMERICAN INDIAN; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; ETHNIC GROUP; ETHNICITY; GENE FREQUENCY; GENETIC ANALYSIS; GENOTYPE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MEXICAN MESTIZO; MEXICO; OXIDATIVE STRESS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; THROMBOPHILIA; ADOLESCENT; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD; CAUCASIAN; ETHNOLOGY; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; PATHOLOGY; POLYMERASE CHAIN REACTION; RISK FACTOR; YOUNG ADULT;

ADOLESCENT; ADULT; ANGIOTENSINOGEN; ASIAN CONTINENTAL ANCESTRY GROUP; DNA; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLUTATHIONE S-TRANSFERASE PI; HUMANS; HYPERTENSION; INDIANS, NORTH AMERICAN; INTEGRIN BETA3; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MEXICO; MIDDLE AGED; OXIDATIVE STRESS; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; THROMBOPHILIA; YOUNG ADULT;

EID: 77954804330     PISSN: 02780240     EISSN: None     Source Type: Journal    
DOI: 10.3233/DMA-2010-0712     Document Type: Article

References (47)

1. T.V. Pereira, A.C. Nunes, M. Rudnicki, Y. Yamada, A.C. Pereira and J.E. Krieger, Meta-analysis of the association of 4 angiotensinogen polymorphisms with essential hypertension: a role beyond M235T? Hypertension 51 (2008), 778-783.
2. J. Mikkelsson, M. Perola, A. Penttilä, P.J. Goldschmidt- Clermont and P.J. Karhunen, The GPIIIa (beta3 integrin) PlA polymorphism in the early development of coronary atherosclerosis, Atherosclerosis 154 (2001), 721-727.
3. J.P. Casas, L.E. Bautista, L. Smeeth, P. Sharma and A.D. Hingorani, Homocysteine and stroke: evidence on a causal link from mendelian randomization, Lancet 365 (2005), 224-232.
4. C.N. Palmer, V. Young, M. Ho, A. Doney and J.J. Belch, Association of common variation in glutathione S-transferase genes with premature development of cardiovascular disease in patients with systemic sclerosis, Arthritis Rheum 48 (2003), 854-855.
5. G. Benze, J. Heinrich, H. Schulte, S. Rust, U. Nowak-Göttl, M.C. Tataru, E. Köhler, G. Assmann and R. Junker, Association of the GPIa C807T and GPIIIa PlA1/A2 polymorphisms with premature myocardial infarction in men, Eur Hear J 23 (2003), 325-330.
6. J. Frederiksen, K. Juul, P. Grande, G.B. Jensen, T.V. Schroeder, A. Tybjaerg-Hansen and B.G. Nordestgaard, Methylenetetrahydrofolate reductase polymorphism (C677T), hyperhomocysteinemia, and risk of ischemic cardiovascular disease and venous thromboembolism: prospective and case-control studies from the Copenhagen City Heart Study, Blood 104 (2004), 3046-3051.
7. R. Ward, Familial aggregation and genetic epidemiology of blood pressure, in: Hypertension: Pathophysiology, Diagnosis and Management, J.H. Laragh and D.M. Brenner, eds, Raven Press, New York, 1990, pp. 81-100.
8. G.A. MacGregor, N.D. Markandu, J.E. Roulston, J.C. Jones and J.J. Morton, Maintenance of blood pressure by the reninangiotensin system in normal man, Nature 291 (1981), 329-331.
9. F. Paillard, D. Chansel, E. Brand, A. Benetos, F. Thomas, S. Czekalski, R. Ardaillou and F. Soubrier, Genotype-phenotype relationships for the renin-angiotensin-aldosterone system in a normal population, Hypertension 34 (1999), 423-429.
10. D.S.Wald, M. Lawand J.K. Morris, Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis, BMJ 325 (2002), 1202.
11. P. Frosst, H.J. Blom, R. Milos, P.Goyette, C.A. Sheppard, R.G. Matthews, G.J. Boers, M. den Heijer, L.A. Kluijtmans and L.P. van den Heuvel, A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase, Nat Genet 10 (1995), 111-113.
12. M.H. Prandini, E. Denarier, P. Frachet, G. Uzan and G. Marguerie, Isolation of the human platelet glycoprotein IIb gene and characterization of the 5-prime flanking region, Biochem Biophys Res Commun 156 (1988), 595-601.
13. P.J. Newman, R.S. Derbes and R.H. Aster, The human platelet alloantigens, PlA1 and PlA2, are associated with a leucine33/proline33 amino acid polymorphism in membrane glycoprotein IIIa, and are distinguishable by DNA typing, J Clin Invest 83 (1989), 1778-1781.
14. A.M. Carter, A.J. Catto, J.M. Bamford and P.J. Grant, Platelet GP IIIa PlA and GP Ib variable number tandem repeat polymorphisms and markers of platelet activation in acute stroke, Arterioscler Throm Vasc Biol 18 (1998), 1124-1131.
15. P.L. Zusterzeel, W. Visser, W.H. Peters, H.W. Merkus, W.L. Nelen and E.A. Steegers, Polymorphism in the glutathione Stransferase P1 gene and risk for preeclampsia, Obstet Gynecol 96 (2000), 50-54.
16. P.L. Zusterzeel, W.H. Peters, M.A. De Bruyn, M.F. Knapen, H.M. Merkus, and E.A. Steegers, Glutathione S-transferase isoenzymes in decidua and placenta of preeclamptic pregnancies, Obstet Gynecol 94 (1999), 1033-1038.
17. F. Cambien and L. Tire, Genetics of cardiovascular diseases: from single mutations to the whole genome, Circulation 116 (2007), 1714-1724.
18. R. Lisker, E. Ramirez, R. Perez-Briceño, J. Granados and V. Babinsky, Gene frequencies and admixture estimates in four Mexican urban centers, Hum Biol 62 (1990), 791-801.
19. C. Bekker-Mendez, J.K. Yamamoto-Furusho, G. Vargas- Alarćon, D. Ize-Ludlow, J. Alcocer-Varela and J. Granados, Haplotype distribution of class II MHC genes in Mexican patients with systemic lupus erythematosus, Scand J Rheumatol 27 (1998), 373-376.
20. C. Gorodezky, C. Alaez, M.N. V́azquez-García, G. de la Rosa, E. Infante, S. Balladares, R. Toribio, E. Ṕerez-Luque and L. Muñoz, The genetic structure ofMexican Mestizos of different locations: tracking back their origins through MHC genes, blood group systems, and microsatellites, Hum Immunol 62 (2001), 979-991.
21. Instituto Nacional de Estadística Geografía e Inforḿatica (INEGI), La poblacíon indígena en Ḿexico, www.inegi.org.mx (2004).
22. J. Sambrook and D. Russell, Preparation and analysis of eukaryotic genomic DNA, in: Molecular Cloning: A Laboratory Manual, C. Nolan, ed., Cold Spring Harbor Laboratory Press, New York, 2001, pp. 6.1-6.31.
23. J. Reynolds, B.S.Weir and C.C. Cockerham, Estimation of the coancestry coefficient: basis for a short-term genetic distance, Genetics 105 (1983), 767-779.
24. Instituto Nacional Indigenista, Informacíon b́asica sobre los pueblos indígenas de Ḿexico, Ḿexico, Instituto Nacional Indigenista, www.sedesol.gob.mx (1999).
25. L. Cavalli-Sforza, Genes, peoples, and languages, Proc Natl Acad Sci USA 94 (1997), 7719-7724.
26. J. Lin, M.R. Spitz, Y.Wang, M.B. Schabath, I.P. Gorlov, L.M. Hernandez, P.C. Pillow, H.B. Grossman and X Wu. Polymorphisms of folate metabolic genes and susceptibility to bladder cancer: a case-control study, Carcinogenesis 25 (2004), 1639-1647.
27. X. Miao, D. Xing, W. Tan, J. Qi, W. Lu and D. Lin, Susceptibility to gastric cardia adenocarcinoma and genetic polymorphisms in methylenetetrahydrofolate reductase in an at-risk Chinese population, Cancer Epidemiol Biomarkers Prev 11 (2002), 1454-1458.
28. T. Keku, R. Millikan, K. Worley, S. Winkel, A. Eaton, L. Biscocho, C. Martin and R. Sandler, 5,10- Methylenetetrahydrofolate reductase codon 677 and 1298 polymorphisms and colon cancer in African Americans and whites, Cancer Epidemiol Biomarkers Prev 11 (2002), 1611-1621.
29. O.M. Mutchinick, M.A. Lopez, L. Luna, J. Waxman and V.E. Babinsky, High prevalence of the thermolabile methylenetetrahydrofolate reductase variant in Mexico: a country with a very high prevalence of neural tube defects, Mol Genet Metab 68 (1999), 461-467.
30. I.P. D́avalos, N. Olivares, M.T. Castillo, J.M. Cant́u, B. Ibarra, L. Sandoval, M.C. Moŕan, M.P. Gallegos, R. Chakraborty and F. Rivas, The C677T polymorphism of the methylenetetrahydrofolate reductase gene in Mexican mestizo neural-tube defect parents, control mestizo and native populations, Ann Genet 43 (2000), 89-92.
31. X. Qian, Z. Lu, M. Tan, H. Liu and D. Lu, A meta-analysis of association between C677T polymorphism in the methylenetetrahydrofolate reductase gene and hypertension, Eur J Hum Genet 15 (2007), 1239-1245.
32. S. Szamosi, Z. Csiki , E. Szomj́ak, E. Szolnoki , G. Szoke , Z. Szekanecz, G. Szegedi, Y. Shoenfeld and G. Szucs, Plasma homocysteine levels, the prevalence of methylenetetrahydrofolate reductase gene C677T polymorphism and macrovascular disorders in systemic sclerosis: risk factors for accelerated macrovascular damage? Clin Rev Allergy Immunol 36 (2009), 145-149.
33. G. Gorgone, F. Ursini, C. Altamura, F. Bressi, M. Tombini, G. Curcio, P. Chiovenda, R. Squitti, M. Silvestrini, R. Ientile, F. Pisani, P.M. Rossini and F. Vernieri, Hyperhomocysteinemia, intima-media thickness and C677T MTHFR gene polymorphism: a correlation study in patients with cognitive impairment, Atherosclerosis 206 (2009), 309-313.
34. I.P. Kosmas, A. Tatsioni and J.P. Ioannidis, Association of C677T polymorphism in the methylenetetrahydrofolate reductase gene with hypertension in pregnancy and preeclampsia: a meta-analysis, J Hypertens 22 (2004), 1655-1662.
35. P. Canto, T. Canto-Cetina, R. Juarez-Velazquez, S. Canizales- Quinteros, H. Rosas-Vargas, H. Rangel-Villalobos, A.C. Veĺazquez-Wong, G. Ferńandez, M.T. Villarreal-Molina and R. Coral-V́azquez, Methylenetetrahydrofolate reductase C677T and glutathione S-transferase P1 A313G are associated with a reduced risk of preeclampsia in Maya-Mestizo women, Hypertens Res 31 (2008), 1015-1019.
36. L. Tiret, Gene-environment interaction: a central concept in multifactorial diseases, Proc Nutr Soc 61 (2002), 457-463.
37. K. Hemminki, J. Lorenzo Bermejo and A. Forsti, The balance between heritable and environmental aetiology of human disease, Nat Rev Genet 7 (2006), 958-965.
38. H. Akasaka, T. Katsuya, S. Saitoh, K.Sugimoto, Y. Fu, S. Takagi, H. Ohnishi, H. Rakugi, N. Ura, K. Shimamoto and T. Ogihara, Effects of angiotensin II type 1 receptor gene polymorphisms on insulin resistance in a Japanese general population: The Tanno-Sobetsu Study, Hypertens Res 29 (2006), 961-967.
39. L.J. Rasmussen-Torvik, K.E. North, C.C. Gu, C.E. Lewis, J.B. Wilk, A. Chakravarti, Y.-P. C. Chang, M.B. Miller, N. Li, R.B. Devereux and D.K. Arnett, A population association study of angiotensinogen polymorphisms and haplotypes with left ventricular phenotypes, Hypertension 46 (2005), 1294-1299.
40. Y. Pei, J. Scholey, K. Thai, M. Suzuki and D. Cattran, Association of angiotensinogen gene T235 variant with progression of immunoglobin a nephropathy in Caucasian patients, J Clin Invest 100 (1997), 814-820.
41. J. Lim, S. La, K.C. Ng, K.-S. Ng, N. Saha and C.-K. Heng, Variation of the platelet glycoprotein IIIa PIA1/A2allele frequencies in the three ethnic groups of Singapore, Int J Cardiol 90 (2003), 269-273.
42. K.R.Wagner,W.H. Giles, C.J. Johnson, C.Y. Ou, P.F. Bray, P.J. Goldschmidt-Clermont, J.B. Croft, V.K. Brown, B.J. Stern, B.R. Feeser, D.W. Buchholz, C.J. Earley, R.F. Macko, R.J. McCarter, M.A. Sloan, P.D. Stolley, R.J. Wityk, M.A. Wozniak, T.R. Price and S.J. Kittner, Platelet glycoprotein receptor IIIa polymorphism P1A2 and ischemic stroke risk: the Stroke Prevention in Young Women Study, Stroke 29 (1998), 581-585.
43. M.A. Carless, R.A. Lea, J.E. Curran, B. Appleyard, P. Gaffney, A. Green and L.R. Griffiths, The GSTM1 null genotype confers an increased risk for solar keratosis development in an Australian Caucasian population, J Invest Dermatol 119 (2002), 1373-1378.
44. J.H. Fowke, X.O. Shu, Q. Dai, A. Shintani, C.C. Conaway, F.L. Chung, Q. Cai, Y.T. Gao and W. Zheng, Urinary isothiocyanate excretion, brassica consumption, and gene polymorphisms among women living in Shanghai, China, Cancer Epidemiol Biomarkers Prev 12 (2003), 1536-1539.
45. M.A.Waton, R.K. Stewart, G.B. Smith, T.E. Massey and D.A. Bell, Human glutathione S-transferase P1 polymorphisms: relationship to lung tissue enzyme activity and population frequency distribution, Carcinogenesis 19 (1998), 275-280.
46. A. Hatagima, E.C. Costa, C.F. Marques, R.J. Koifman, P. Boffetta and S. Koifman, Glutathione S-transferase polymorphisms and oral cancer: a case-control study in Rio de Janeiro, Brazil, Oral Oncol 44 (2008), 200-207.
47. E.E. Hollenbach, El parentesco entre los triques de Copala, Oaxaca, Aḿerica Indígena 33 (1973), 167-186.